Privacert, Inc. is an early commercial provider of shared-data risk assessment and scientific assurance technologies for anonymity. Its focus is not firewalls, intrusion detection, or encryption, but assessing whether βdata proactively delivered to third partiesβ still carries a risk of identifying individuals. The material centers on the HIPAA Privacy Rule, especially data de-identification under the Safe Harbor provisions and the Expert Determination standard.
Privacert offers Risk Assessments and the Privacert HIPAA Standard to determine whether datasets are sufficiently de-identified from both scientific and legal perspectives, so they can be shared freely while retaining utility. Its approach attempts to measure the minimum re-identification risk under the Expert Determination standard, based on the number of identifiable individuals allowed under the HIPAA Safe Harbor provisions. The text also notes that its technology has been used in high-profile data-sharing arrangements and is positioned for regulatory environments such as HIPAA, the EU Data Directive, and the Gramm-Leach-Bliley Act.
The text mentions that four organizations licensed the Privacert Risk Assessment Server in 2002, indicating that a server licensing model existed historically. However, the page does not state whether it currently offers on-premises deployment, SaaS, managed services, or pure consulting assessments. There is also no description of modern enterprise security capabilities such as an admin console, automated alerts, reporting, APIs, SIEM integration, or data platform integrations. A VAR value-added reseller program is mentioned, but this is not enough to assess the actual integration ecosystem.
The text does not disclose pricing, trials, subscriptions, project-based fees, or licensing costs, nor does it provide details on service levels, response times, or support channels. The page only lists an email address, office address, phone number, and fax number, so buyers should contact the company directly before procurement to confirm current business status, delivery scope, and the boundaries of legal responsibility.
Its strengths are a highly specialized positioning, a focus on re-identification risk and compliance evidence before data sharing, and an academic and early-practice background. It may be useful as a reference for healthcare data releases, research data sharing, and government or enterprise open-data projects. Its weaknesses are that the publicly available materials appear clearly outdated, with limited productization details and no visible modern security operations capabilities. It is also mainly framed around the U.S. HIPAA context, with no explanation of how it maps to Chinaβs PIPL, Data Security Law, Cybersecurity Law, or related requirements.
Access, payment, and contract support for mainland China are unknown. If a project is primarily driven by China-local compliance, organizations should first evaluate local vendors for data masking, data security governance, privacy-enhancing computation, or anonymization assessment. If the project involves U.S. healthcare data or HIPAA de-identification, Privacert may be worth further due diligence as a specialist methodology or vendor lead.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on privacert.com official site.
privacert.com is an United States Cybersecurity provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach privacert.com directly.